| Identification | More | [Name]
BOC-L-3,5-DIFLUOROPHE | [CAS]
205445-52-9 | [Synonyms]
BOC-PHE(M-F2)-OH
BOC-PHE(3,5-DIF)-OH
BOC-PHE(3,5-F 2)-OH
BOC-L-3,5-DIFLUOROPHE
Boc-L-Phe(3,5-DiF)-OH
Boc-L-3,5-Difluoro-phe-OH
BOC-L-3,5-DIFLUOROPHENYLALANINE
BOC-3,5-DIFLUORO-L-PHENYLALANINE
N-Boc-L-3,5-difluorophenylalanine
N-BOC-3,5-DIFLUORO-L-PHENYLALANINE
(S)-N-Boc-3,5-difluorophenylalanine
(Tert-Butoxy)Carbonyl Phe(3,5-DiF)-OH
N-Boc-L-3,5-difluorophenylalanine,99%e.e.
3,5-DIFLUORO-L-PHENYLALANINE, BOC PROTECTED
3,5-Difluoro-L-phenylalanine,-NBOCprotected
Boc-3,5-difluoro-L-phenylalanine≥ 99% (HPLC)
Boc-Phe(3,5-F2)-OH Boc-3,5-Difluoro-D-Phenylalanine
(S)-Boc-2-amino-3-(3,5-difluorophenyl)propionic acid
N-ALPHA-T-BUTOXYCARBONYL-L-(3,5-DIFLUOROPHENYL)ALANINE
L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-3,5-difluoro-
(S)-2-(tert-butoxycarbonylamino)-3-(3,5-difluorophenyl)propanoic acid
(S)-2-TERT-BUTOXYCARBONYLAMINO-3-(3,5-DIFLUORO-PHENYL)-PROPIONIC ACID
(2S)-2-{[(tert-butoxy)carbonyl]aMino}-3-(3,5-difluorophenyl)propanoic acid | [Molecular Formula]
C14H17F2NO4 | [MDL Number]
MFCD00797555 | [Molecular Weight]
301.29 | [MOL File]
205445-52-9.mol |
| Chemical Properties | Back Directory | [Melting point ]
115℃ | [Boiling point ]
417.6±45.0 °C(Predicted) | [density ]
1.270±0.06 g/cm3(Predicted) | [storage temp. ]
Store at 0°C | [form ]
solid | [pka]
3.73±0.10(Predicted) | [color ]
White | [Optical Rotation]
-18.6°(C=1.10g/100ml DMSO) | [Major Application]
peptide synthesis | [InChI]
InChI=1S/C14H17F2NO4/c1-14(2,3)21-13(20)17-11(12(18)19)6-8-4-9(15)7-10(16)5-8/h4-5,7,11H,6H2,1-3H3,(H,17,20)(H,18,19)/t11-/m0/s1 | [InChIKey]
CZBNUDVCRKSYDG-NSHDSACASA-N | [SMILES]
C(O)(=O)[C@H](CC1=CC(F)=CC(F)=C1)NC(OC(C)(C)C)=O | [CAS DataBase Reference]
205445-52-9(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [WGK Germany ]
3 | [Hazard Note ]
Irritant | [HS Code ]
2922498590 | [Storage Class]
11 - Combustible Solids |
| Hazard Information | Back Directory | [Chemical Properties]
White to off-white powder | [Uses]
Used as pharmaceutical intermediates. | [reaction suitability]
reaction type: Boc solid-phase peptide synthesis |
|
|